Cargando…

Signals for Hepatic Figrogenesis in Pediatric Cholestatic Liver Disease: Review and Hypothesis

Detalles Bibliográficos
Autores principales:	Ramm, Grant A, Hoskins, Anita C, Greco, Sonia A, Pereira, Tamara N, Lewindon, Peter J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Proceedings
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2410228/ https://www.ncbi.nlm.nih.gov/pubmed/14960157 http://dx.doi.org/10.1186/1476-5926-2-S1-S5

Ejemplares similares

Function and Regulation of MicroRNAs and Their Potential as Biomarkers in Paediatric Liver Disease
por: Calvopina, Diego A., et al.
Publicado: (2016)

Towards validating the hypothesis of phylogenetic profiling
por: Loganantharaj, Raja, et al.
Publicado: (2007)

An empirical evaluation of the common disease-common variant hypothesis
por: Chen, Gary K, et al.
Publicado: (2007)

GOModeler- A tool for hypothesis-testing of functional genomics datasets
por: Manda, Prashanti, et al.
Publicado: (2010)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Azathioprine induced cholestatic hepatitis
por: Moses, Viju, et al.
Publicado: (2011)

Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017)

Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations
por: Taylor, Sarah A., et al.
Publicado: (2021)

Review: Pathogenesis of cholestatic liver diseases
por: Yokoda, Raquel T, et al.
Publicado: (2020)

The role of Mesothelin signaling in Portal Fibroblasts in the pathogenesis of cholestatic liver fibrosis
por: Fuji, Hiroaki, et al.
Publicado: (2021)

Genome-wide association studies of rheumatoid arthritis data via multiple hypothesis testing methods for correlated tests
por: Kang, Guolian, et al.
Publicado: (2009)

Sofosbuvir and Simeprevir for the Treatment of Recurrent Hepatitis C with Fibrosing Cholestatic Hepatitis after Liver Transplantation
por: Issa, D., et al.
Publicado: (2016)

The Metrizer: an innovative device for achieving virtual hepatic biopsies
por: Russo, Carlo, et al.
Publicado: (2013)

Nonoperative management for patients with grade IV blunt hepatic trauma
por: Zago, Thiago Messias, et al.
Publicado: (2012)

Cholestatic hepatitis due to Salmonella typhi
por: Albayrak, Ayse, et al.
Publicado: (2011)

Echinacea-associated acute cholestatic hepatitis
por: Gabranis, I, et al.
Publicado: (2015)

Mechanisms of Hepatic Cholestatic Drug Injury
por: Kolarić, Tea Omanović, et al.
Publicado: (2019)

Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease
por: Shneider, Benjamin L., et al.
Publicado: (2020)

Antioxidant Enzyme Activities in Hepatic Tissue from Children with Chronic Cholestatic Liver Disease
por: Ismail, Nagwa A., et al.
Publicado: (2010)

Role of Hepatic Stellate Cells in the Early Phase of Liver Regeneration in Rat: Formation of Tight Adhesion to Parenchymal Cells
por: Mabuchi, Ayako, et al.
Publicado: (2004)

Precision-cut liver slices in culture as a tool to assess the physiological involvement of Kupffer cells in hepatic metabolism
por: Neyrinck, Audrey M, et al.
Publicado: (2004)

Liver Transplantation for Patients with Cholestatic Liver Diseases
por: Schöning, Wenzel, et al.
Publicado: (2015)

The Gut-Liver Axis in Cholestatic Liver Diseases
por: Blesl, Andreas, et al.
Publicado: (2021)

Bile acid-mediated signaling in cholestatic liver diseases
por: Zeng, Jing, et al.
Publicado: (2023)

Fibrosing cholestatic hepatitis C in post-transplant adult recipients of liver transplantation
por: Hori, Tomohide, et al.
Publicado: (2016)

Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury
por: Cai, Shi-Ying, et al.
Publicado: (2017)

Nivolumab-Induced Autoimmune-Like Cholestatic Hepatitis in a Liver Transplant Recipient
por: Anugwom, Chimaobi, et al.
Publicado: (2020)

Fibrosis in Autoimmune and Cholestatic Liver Disease
por: Penz-Österreicher, Melitta, et al.
Publicado: (2011)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

The Role of Inflammation in Cholestatic Liver Injury
por: Chen, Jie, et al.
Publicado: (2023)

Fibrotic Events in the Progression of Cholestatic Liver Disease
por: Wu, Hanghang, et al.
Publicado: (2021)

Signaling role of iron in NF-kappa B activation in hepatic macrophages
por: Xiong, Shigang, et al.
Publicado: (2004)

Human Hepatocellular response in Cholestatic Liver Diseases
por: Ortiz, Kimberly, et al.
Publicado: (2023)

Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis
por: Ozkan, Tanju Basarir, et al.
Publicado: (2007)

Carbimazole-induced cholestatic hepatitis in Graves’ disease
por: Kota, Sunil K., et al.
Publicado: (2013)

Nafcillin-Induced Allergic Eosinophilic Cholestatic Hepatitis
por: Guido, Mark V., et al.
Publicado: (2017)

Giant Cell Arteritis Presenting as Cholestatic Hepatitis
por: Riordan, Gerald, et al.
Publicado: (2021)

Keratin 7 expression in hepatic cholestatic diseases
por: Sakellariou, S., et al.
Publicado: (2021)

Tozinameran: Severe cholestatic hepatitis: case report
Publicado: (2021)

PPAR Gamma and Hepatic Stellate Cells
por: Hazra, Saswati, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_a73fglkhidqao7acpn736q481e